ADMA Biologics
ADMA
ADMA
24 hedge funds and large institutions have $65.1M invested in ADMA Biologics in 2015 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
4% less capital invested
Capital invested by funds: $68.1M → $65.1M (-$3.01M)
Holders
24
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$417K | |
| 2 | +$319K | |
| 3 | +$119K | |
| 4 |
PCM
Prelude Capital Management
New York
|
+$64K |
| 5 |
TI
Telemetry Investments
New York
|
+$31K |
Top Sellers
| 1 | -$294K | |
| 2 | -$39.8K | |
| 3 | -$22.5K | |
| 4 |
Goldman Sachs
New York
|
-$21.3K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.36K |